Spondyloarthritis Research And Treatment Network is located in Portland, OR. The organization was established in 2015. According to its NTEE Classification (G51) the organization is classified as: Arthritis, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Spondyloarthritis Research And Treatment Network is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 07/2023, Spondyloarthritis Research And Treatment Network generated $1.1m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 8.3% each year. All expenses for the organization totaled $820.3k during the year ending 07/2023. While expenses have increased by 14.7% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2020, Spondyloarthritis Research And Treatment Network has awarded 13 individual grants totaling $270,000. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
OUR MISSION IS TO FOSTER SPONDYLOARTHRITIS RESEARCH AND EDUCATION IN NORTH AMERICA. WE ACCOMPLISH THIS MISSION BY ENGAGING IN RESEARCH PROJECTS, SUPPORTING YOUNG RESEARCHERS, AND CONDUCTING AN ANNUAL MEETING HIGHLIGHTING IMPORTANT EDUCATION AND RESEARCH PROGRAMS. OUR VISION IS A WORLD FREE OF SPONDYLOARTHRITIS THROUGH LEADERSHIP IN RESEARCH AND EDUCATION.
Describe the Organization's Program Activity:
Part 3 - Line 4a
SPARTAN ANNUAL MEETINGSPARTAN HOLDS AN ANNUAL MEETING TO HIGHLIGHT ADVANCES IN SPONDYLOARTHRITIS RESEARCH AND TREATMENT AND ENCOURAGE POST-DOCTORAL FELLOWS TO ENGAGE IN THE SPARTAN MISSION OF FOSTERING RESEARCH AND EDUCATION IN THE FIELD OF SPONDYLOARTHRITIS (SPA). THE RESEARCH AND EDUCATION MEETING IS ALSO AN OPPORTUNITY TO BRING TOGETHER EXPERT, DEDICATED RESEARCHERS TO IDENTIFY AND ADDRESS UNMET NEEDS IN THE FIELD OF SPA RESEARCH AND THERAPY. THE HYBRID MEETING IS ATTENDED BY SPARTAN MEMBERS FROM THROUGHOUT NORTH AMERICA - WITH ATTENDANCE OF 130 IN CLEVELAND, OHIO AND 50 VIRTUALLY. PRESENTERS IN THE SCIENTIFIC SESSIONS ARE THE PROMINENT INTERNATIONAL EXPERTS IN THEIR FIELDS. THE SPONDYLOARTHRITIS REVIEW COURSE IS A PRE-MEETING WORKSHOP FOR RHEUMATOLOGY FELLOWS AND OTHER TRAINEES. WE CONDUCTED AN MRI WORKSHOP ATTENDED BY MORE THAN 75 LEARNERS.
SPARTAN RESEARCH PROJECTSCLASSIC (CLASSIFICATION OF AXIAL SPONDYLOARTHRITIS INCEPTION COHORT)THE PRIMARY STUDY OBJECTIVE IS TO TEST ("VALIDATE") THE PERFORMANCE OF THE CURRENT ASAS CLASSIFICATION CRITERIA IN A PROSPECTIVE COHORT OF PATIENTS PRESENTING WITH UNDIAGNOSED CHRONIC BACK PAIN TO RHEUMATOLOGISTS AT NORTH AMERICAN SITES IN US, MEXICO, AND CANADA GREATER THAN OR EQUAL TO 3 MONTHS DURATION WITH ONSET LESS THAN OR EQUAL TO 45 YEARS OF AGE. THE STUDY IS EXPECTED TO BE COMPLETED IN 2023 WITH 500 PATIENTS AT 25 SITES.BASIS (BIOMARKERS IN AXIAL SPONDYLOARTHRITIS INVESTIGATIVE STUDY) THE PRIMARY OBJECTIVE IS TO ESTABLISH A WELL-CHARACTERIZED BIOBANK FOR AXSPA AND IDENTIFY A DIAGNOSTIC BIOMARKER(S) UTILIZING A CROSS-SECTIONAL STUDY OF INDIVIDUALS WITHIN THE SPECTRUM OF AXSPA. THE BASIS STEERING COMMITTEE HAS DEVELOPED THE STUDY BUDGET AND DOCUMENTS AND IS SEEKING INDUSTRY SUPPORT.
SPARTAN GRANTSTHE MISSION OF SPARTAN IS TO ADVANCE RESEARCH AND EDUCATION TO IMPROVE THE CARE OF PATIENTS WITH SPONDYLOARTHRITIS. WE FEEL STRONGLY THAT LAYING THE FOUNDATION FOR THE NEXT GENERATION OF RESEARCHERS AND LEADERS IN SPA IS AN IMPORTANT PORTAL TO ACHIEVE THIS MISSION. THE GOAL OF OUR GRANT PROGRAMS IS TO SUPPORT THE EARLY STAGES OF A FELLOW-LED RESEARCH PROJECT. WITH THE AIM OF ENCOURAGING FELLOWS TO TAKE UP RESEARCH PROJECTS UNDER MENTORS WITH EXPERTISE IN SPA, SPARTAN SUPPORTS TO 2 MENTORED FELLOWSHIP PROJECTS EACH YEAR ($10,000 PER PROJECT - WITH $5000 EACH FOR THE MENTOR AND MENTEE). SPARTAN'S SEED FUND GRANT SUPPORTS EARLY CAREER INVESTIGATORS WHO ARE WORKING IN THE FIELD OF AXIAL SPONDYLOARTHRITIS AND HAS BEEN RENAMED THE EARLY CAREER INVESTIGATOR (ECI) AWARD WITH UP TO 2 NEW GRANTS SUPPORTED ($25,000 PER PROJECT PER YEAR FOR TWO YEARS) ANNUALLY. TRAVEL AWARDS GO TO THE TOP 3 ABSTRACTS TO SUPPORT TRAVEL TO INDUSTRY MEETINGS (3 AWARDS @ $1000 EACH).
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Matthew Stoll PHD MD Treasurer | OfficerTrustee | 4 | $0 |
Joerg Ermann MD Chair | OfficerTrustee | 10 | $0 |
Judith Smith PHD MD Past Chair | OfficerTrustee | 2 | $0 |
Siba Raychaudhuri MD Director | Trustee | 1 | $0 |
Maureen Dubreuil MD Director | Trustee | 3 | $0 |
Nigil Haroon PHD MD Director | Trustee | 3 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $510,000 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $489,000 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $999,000 |
Total Program Service Revenue | $66,600 |
Investment income | $0 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $1,072,855 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $100,660 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $10,000 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $116,163 |
Compensation of current officers, directors, key employees. | $96,000 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $5,115 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $93,192 |
Advertising and promotion | $0 |
Office expenses | $4,401 |
Information technology | $1,780 |
Royalties | $0 |
Occupancy | $0 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $194,205 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $1,922 |
All other expenses | $0 |
Total functional expenses | $820,283 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $432,349 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $400,000 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $2,211,512 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $3,043,861 |
Accounts payable and accrued expenses | $201,874 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $201,874 |
Net assets without donor restrictions | $2,596,137 |
Net assets with donor restrictions | $245,850 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $3,043,861 |
Over the last fiscal year, Spondyloarthritis Research And Treatment Network has awarded $35,000 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
OREGON HEALTH & SCIENCE UNIVERSITY PURPOSE: SPONDYLOARTHRITIS RESEARCH GRANT | $10,000 |
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON PURPOSE: SPONDYLOARTHRITIS RESEARCH GRANT | $25,000 |
Organization Name | Assets | Revenue |
---|---|---|
Northwest Autism Center Spokane, WA | $589,835 | $2,363,324 |
Hand Therapy Certification Commission Inc Sacramento, CA | $2,150,324 | $889,830 |
Spondyloarthritis Research And Treatment Network Portland, OR | $3,043,861 | $1,072,855 |
International Disk Equipment And Materials Association Plumas Lake, CA | $1,364,298 | $1,380,003 |
Northwest Arthritis Institute Seattle, WA | $279,880 | $136,033 |
The Right Hand Foundation Los Altos, CA | $1,601,640 | $143,282 |
Hip Sen Benevolent Association Daly City, CA | $3,448,667 | $204,556 |
Frances M Hamburger Phd Institute For Community Rheumatolo Los Angeles, CA | $302,167 | $56,606 |
Rheumatoid Arthritis Project Spokane, WA | $405,104 | $34,962 |
Sierra Arthritis Foundation Irvine, CA | $1,992 | $40 |